RFK Jr. continues as HHS Secretary with strong administration alignment more than 18 months into his term, actively promoting the MAHA agenda through recent Midwest campaign events and federal announcements on autism safety initiatives ahead of the midterms. White House officials have highlighted his value as a surrogate to boost Republican turnout in competitive districts, with no public signals of impending departure or loss of presidential support despite ongoing criticism from public health organizations and leadership turnover at agencies like the FDA. His Senate-confirmed position runs through 2029, and trader pricing at roughly 74.5% for “No” reflects the absence of imminent exit triggers such as resignation announcements or structural changes that would alter the current consensus.